Information Provided By:
Fly News Breaks for February 13, 2020
UNH, TNDM
Feb 13, 2020 | 07:27 EDT
Cowen analyst Ryan Blicker raised his price target on Tandem Diabetes (TNDM) to $85 from $70 as he views the near-term setup is attractive with Control-IQ likely to drive upside versus near-term estimates, UnitedHealth (UNH) could be a near-term catalyst, and the elevated short interest. Ryan reiterated his Outperform rating on Tandem Diabetes shares.
News For TNDM;UNH From the Last 2 Days
UNH
Apr 25, 2024 | 10:38 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here
TNDM
Apr 25, 2024 | 06:02 EDT
Leerink upgraded Tandem Diabetes to Outperform from Market Perform with a $45 price target.
UNH
Apr 24, 2024 | 16:14 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here